2 ',3 '-Cyclic GMP-AMP Dinucleotides for STING-Mediated Immune Modulation: Principles, Immunotherapeutic Potential, and Synthesis

Mengdi Shang,Kuan Lu,Wenli Guan,Shujie Cao,Mengtian Ren,Chuanzheng Zhou
DOI: https://doi.org/10.1002/cmdc.202100671
IF: 3.54
2022-01-01
ChemMedChem
Abstract:The cGAS-STING pathway discovered ten years ago is an important component of the innate immune system. Activation of cGAS-STING triggers downstream signalling, such as TBK1-IRF3, NF-kappa B and autophagy, which in turn leads to antipathogen responses, durable antitumour immunity or autoimmune diseases. 2 ',3 '-Cyclic GMP-AMP dinucleotides (2 ',3 '-cGAMP), the key second messengers produced by cGAS, play a pivotal role in cGAS-STING signalling by binding and activating STING. Thus, 2 ',3 '-cGAMP has immunotherapeutic potential, which in turn has stimulated research on the design and synthesis of 2 ',3 '-cGAMP analogues for clinical applications over the past ten years. This review presents the discovery, metabolism, and function of 2 ',3 '-cGAMP in the cGAS-STING innate immune signalling axis. The enzymatic and chemical syntheses of 2 ',3 '-cGAMP analogues as STING-targeting therapeutics are also summarized.
What problem does this paper attempt to address?